Literature DB >> 4390667

The effects of pronethalol and propranolol on the coronary circulation of the dog.

W G Davis, D C MacDonald, D F Mason.   

Abstract

1. The actions of pronethalol and propranolol have been studied to see if there was any relationship between the reduction in coronary flow and any other cardiovascular action they have.2. The experiments were carried out in anaesthetized open chest dogs. Measurements included central arterial, left and right venous or atrial pressures, heart rate, ventricular size and stroke volume, intra-ventricular pressures, total left coronary flow, arterial and coronary sinus blood pO(2). The pressure-time index (PTI) and maximum rate of isovolumetric contraction (dp/dt) were obtained from these records.3. It was concluded that, in these experiments, the reduction in coronary flow produced by pronethalol and propranolol was not directly related to a decrease in perfusion pressure, a raised venous pressure, the increase in ventricular volume and hence wall tension, the decrease in heart rate, or to the increased duration of systole.4. The PTI and dp/dt were always reduced at the same time as the coronary flow. These findings are discussed.5. Studies of the effects of sympathetic stimulation, of phentolamine, of reduced arterial oxygen tension and electrical pacing of the heart, all after beta-blockade, did not support the suggestion that the reduction in coronary flow after beta-blockade was due to the unmasking of an active vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4390667      PMCID: PMC1703682          DOI: 10.1111/j.1476-5381.1969.tb10571.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Anatomy of the septal artery in dogs' hearts.

Authors:  K B WOLFE
Journal:  Am J Surg       Date:  1959-03       Impact factor: 2.565

2.  The relation of cardiac effort to myocardial oxygen consumption and coronary flow.

Authors:  L N KATZ; H FEINBERG
Journal:  Circ Res       Date:  1958-09       Impact factor: 17.367

3.  Effects of hemolyzed blood on coronary blood flow.

Authors:  J R CHAMBLISS; J DEMMING; K WELLS; W W CLINE; R W ECKSTEIN
Journal:  Am J Physiol       Date:  1950-12

4.  A special cannula for determination of blood flow in the left common coronary artery of the dog.

Authors:  R W ECKSTEIN; J A McEACHEN; J DEMMING; W B NEWBERRY
Journal:  Science       Date:  1951-04-06       Impact factor: 47.728

5.  Effects of beta-blockade on coronary flow.

Authors:  D A Chamberlain; W G Davis; D F Mason
Journal:  Lancet       Date:  1967-12-09       Impact factor: 79.321

6.  Effects of adrenaline and noradrenaline on coronary blood flow before and after beta-adrenergic blockade.

Authors:  P G Gaal; A A Kattus; A Kolin; G Ross
Journal:  Br J Pharmacol Chemother       Date:  1966-03

7.  Evaluation of sympathetic beta-receptor blockade by recording the rate of ventricular pressure rise in cats.

Authors:  B G Benfey; K Greeff; E Heeg
Journal:  Br J Pharmacol Chemother       Date:  1967-05

8.  Motor innervation of the coronary arteries of the cat.

Authors:  A M Brown
Journal:  J Physiol       Date:  1968-09       Impact factor: 5.182

9.  Myocardial vascular reactivity after beta-adrenergic blockade.

Authors:  J R Parratt; J Grayson
Journal:  Lancet       Date:  1966-02-12       Impact factor: 79.321

10.  Effect of propranolol on alpha-adrenergic blockade in the dog and isolated rabbit aortic strip.

Authors:  G J Olivares; N T Smith; L Aronow
Journal:  Br J Pharmacol Chemother       Date:  1967-06
View more
  2 in total

1.  General concepts in the use of beta-blockers: the relative roles of specific and unspecific effects.

Authors:  H Brunner; P R Hedwall; M Meier
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

2.  The action of aminophylline on the acutely transplanted dog heart: effect of alpha- and beta-adrenoceptor blockade.

Authors:  H J Paoloni; D E Wilcken
Journal:  Br J Pharmacol       Date:  1975-02       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.